机译:Lorcaserin的使用减少了对食物线索的响应,并且这些与情绪和显着性相关的变化与减肥效果相关:一项为期4周的随机,安慰剂对照,双盲临床试验
Division of Endocrinology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA;
Division of Endocrinology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA;
Division of Endocrinology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA;
Division of Endocrinology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA;
Division of Endocrinology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA;
Division of Endocrinology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA;
Boston University Medical Center, Boston, MA;
Division of Endocrinology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA;
Division of Endocrinology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA;
Division of Endocrinology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA;
Division of Endocrinology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA;
Division of Endocrinology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA;
Division of Endocrinology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA;
机译:孜然加石灰对超重对象的体重减轻和代谢状态的影响:随机双盲安慰剂对照临床试验
机译:双盲,多中心,随机,安慰剂对照的临床试验,在原发性经皮冠状动脉介入治疗之前对ST抬高型心肌梗死的患者早期给予静脉内β-受体阻滞剂:早期β-受体阻滞剂在患者初次PCI之前的给药与ST抬高型心肌梗死试验
机译:lorcaserin用于2型糖尿病减肥的随机安慰剂对照临床试验:BLOOM-DM研究
机译:Lorcaserin的使用减少了对食物线索的响应并且这些与情绪和显着性相关的变化与减肥效果相关:一项为期4周的随机安慰剂对照双盲临床试验
机译:Lorcaserin给药在对食品提示的反应和这些情绪和显着相关的变化与减肥效应相关的影响下降:4周长的随机,安慰剂控制,双盲临床试验
机译:高剂量阿托伐他汀减少免疫激活的细胞标记而不影响HIV-1 RNa水平:双盲随机安慰剂对照临床试验的结果